Celon Pharma SA (CLN) — Capital Reinvestment Ratio
Celon Pharma SA (CLN) has a Capital Reinvestment Ratio of 6.28x as of June 2025, meaning it reinvests 6% of its operating cash flow (zł3.51 Million) in capital expenditures (zł22.07 Million). See how leveraged is Celon Pharma SA's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Celon Pharma SA Capital Reinvestment Ratio (2012–2021)
This chart tracks Celon Pharma SA's Capital Reinvestment Ratio across 9 annual periods. Check CLN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Celon Pharma SA (2012–2021)
Year-by-year Capital Reinvestment Ratio for Celon Pharma SA from 2012 to 2021. For live market cap and broader valuation context, see CLN market cap overview.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.94x | zł43.95 Million | zł41.35 Million | ▼ -32.7% |
| 2020 | 1.40x | zł70.90 Million | zł99.16 Million | ▼ -41.5% |
| 2018 | 2.39x | zł28.24 Million | zł67.46 Million | ▲ +92.9% |
| 2017 | 1.24x | zł25.30 Million | zł31.34 Million | ▲ +20.1% |
| 2016 | 1.03x | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł12.87 Million | zł4.34 Million | — |